These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6043564)

  • 1. [Biochemical studies in progressive muscular dystrophy. II. Changes of glycogen, potassium, and total and residual nitrogen. Oxygen consumption with endogenous and exogenous substrates].
    Duma D; Popoviciu L; Mareş V; Serban M; Pîrvu M; Lazăr TC; Pop R; Băltescu V
    Stud Cercet Neurol; 1967; 12(2):85-91. PubMed ID: 6043564
    [No Abstract]   [Full Text] [Related]  

  • 2. [Carnosine and anserine content of muscles in the course of progressive muscular dystrophy].
    Stepanova NG; Grinio LP
    Vopr Med Khim; 1968; 14(2):210-4. PubMed ID: 5682163
    [No Abstract]   [Full Text] [Related]  

  • 3. [Sideremia and muscular myoglobin in progressive muscular dystrophy and other neuromuscular diseases].
    Buscaino GA
    Acta Neurol (Napoli); 1966; 21(1):26-32. PubMed ID: 5999243
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biochemical research in progressive muscular dystrophy. I. Study of tissue respiration and the free sulfhydryl groups of muscular tissue].
    Duma D; Popoviciu L; Proinov I; Lazăr TC; Cătană R; Serban M; Mareş V; Abrudan M
    Stud Cercet Neurol; 1966; 11(2):99-105. PubMed ID: 5941631
    [No Abstract]   [Full Text] [Related]  

  • 5. [Carbohydrate metabolism disorders in hereditary forms of neuromuscular diseases].
    Golubeva VV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1971; 71(8):1153-9. PubMed ID: 5136819
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies of muscular proteins and protein nitrogen in chronic uremia].
    Campanacci L; Maschio G; Bruschi E; Poli D; Mioni G; Bazzato G; Galanti G; Blasina B
    Minerva Nefrol; 1969; 16(1):23-32. PubMed ID: 5768264
    [No Abstract]   [Full Text] [Related]  

  • 7. [The muscular clearance of Na24 in amyotrophic syndromes].
    Radu H; Blücher G; Gödri I
    Rev Neurol (Paris); 1967 Jan; 116(1):81-4. PubMed ID: 6032289
    [No Abstract]   [Full Text] [Related]  

  • 8. [Features of disorders of carbohydrate metabolism in progressive muscular dystrophies (review)].
    Badalian LO; Temin PA; Ametov AS; Khasanova KhD; Il'in IL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(3):122-6. PubMed ID: 6344519
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes in the content of water, electrolytes, glycogen and protein and nonprotein nitrogen in the skeletal muscle of uremic patients in intermittent hemodialytic treatment].
    Maschio G; Mioni G; Bazzato G; Bruschi E; Guarnieri GF; Blasina B; Bertaglia E
    Minerva Nefrol; 1968; 15(5):331-5. PubMed ID: 5743461
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current theories on the pathogenesis of muscular dystrophy].
    Davidenkova EF; Shvarts EI; Rozenberg OA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1971; 71(10):1446-52. PubMed ID: 5139404
    [No Abstract]   [Full Text] [Related]  

  • 11. Muscular dystrophy: potassium exchange in residual muscle.
    SHY GM; CUMMINGS DJ; BERG L; HORVATH B
    J Appl Physiol; 1955 Jul; 8(1):33-6. PubMed ID: 13242488
    [No Abstract]   [Full Text] [Related]  

  • 12. [Adrenergic structures and monoamine oxidase activity in dystrophic skeletal muscles].
    Badalian LO; Severina IS; Grinio LP; Temin PA; Amanova ZN
    Biull Eksp Biol Med; 1984 Jun; 97(6):660-2. PubMed ID: 6743800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogenolytic enzymes in human progressive muscular dystrophy.
    SCHAPIRA G; DREYFUS JC; SCHAPIRA F; KRUH J
    Am J Phys Med; 1955 Feb; 34(1):313-9. PubMed ID: 14361709
    [No Abstract]   [Full Text] [Related]  

  • 14. Examination with autoradiography of the intrafibrillar potassium in atrophized muscles.
    Kállay N
    Acta Biochim Biophys Acad Sci Hung; 1972; 7(1):83-8. PubMed ID: 5084292
    [No Abstract]   [Full Text] [Related]  

  • 15. Muscular dystrophy: cation concentrations in residual muscle.
    HORVATH B; BERG L; CUMMINGS DJ; SHY GM
    J Appl Physiol; 1955 Jul; 8(1):22-30. PubMed ID: 13242486
    [No Abstract]   [Full Text] [Related]  

  • 16. [Succinic dehydrogenase activity in the skeletal muscles of children in diseases of the locomotor apparatus].
    Iaroshevskaia EN
    Arkh Patol; 1965; 27(7):63-5. PubMed ID: 5865149
    [No Abstract]   [Full Text] [Related]  

  • 17. Potassium permeability in isolated skeletal muscle from mice with muscular dystrophy.
    Lipicky RJ; Hess J
    Am J Physiol; 1974 Mar; 226(3):592-6. PubMed ID: 4817411
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lipoid changes in progressive muscular dystrophy].
    Schellnack K
    Beitr Orthop Traumatol; 1970 Jan; 17(1):91-5. PubMed ID: 5511214
    [No Abstract]   [Full Text] [Related]  

  • 19. [Catecholamine concentration in the blood and excretion in the urine in different forms of progressive muscular dystrophy].
    Badalian LO; Temin PA; Dzhabarov BD; Bespalova VA; Kret LA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(3):339-42. PubMed ID: 6426220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [THE LEVEL OF POTASSIUM IN DYSTROPHIC MUSCLES].
    NIEBROJ DOBOSZ I; HAUSMANOWA PETRUSEWICZ I
    Neurol Neurochir Psychiatr Pol; 1963; 13():461-8. PubMed ID: 14079929
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.